2m 2m 2m 2m 2m 2m 2m
ARS Pharma (SPRY)
NASDAQ
$4.30-$0.03 (-0.58%)
Price as of Oct 22, 2026 7:30 PM EDT- $415.7MMarket Cap
- -57.00%1-Year Change
- BiotechnologyIndustry
ARS Pharma (SPRY)
$4.30-$0.03 (-0.58%)
SPRY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.32 | ||
Change | -$0.11 (-2.56%) | ||
Open | $4.13 | ||
High | $4.36 | ||
Low | $4.13 | ||
Previous Close | $4.18 | ||
Volume | 1,787,746 | ||
30-Day Average Volume | 1,451,508 | ||
1-Week Change | 6.36% | ||
1-Month Change | -3.91% | ||
1-Year Change | -57.00% | ||
3-Year Change | 19.09% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 99.4M | ||
Total Assets | $249.5M | ||
Market Cap | $415.7M | ||
Enterprise Value | $504.2M | ||
Period: QTR TTM FY | |||
Revenue | $26.2M | ||
Net Income | -$62.3M | ||
Free Cash Flow | -$60.9M | ||
EBIT | -$62.3M | ||
EBITDA | -$61.9M | ||
Net Working Capital | $150.6M | ||
EPS | -$0.63 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | 19 | ||
P/B | 33 | ||
P/E | -7 | ||
PEG | 2 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue